Aortic biological valve thrombosis in an HIV positive patient

Annals of Thoracic Surgery

Volumn 91, Issue 6, 2011, Pages

  Achouh, Paul ^a,b   Jemel, Amine ^a,b   Chaudeurge, Aurélie ^a,b   Redheuil, Alban ^a   Zegdi, Rachid ^a,b   Fabiani, Jean Noël ^a,b  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; EFAVIRENZ; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; HEPARIN;

ADULT; AORTA THROMBOSIS; AORTA VALVE; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; ARTICLE; BIOPROSTHESIS; CASE REPORT; CATHETERIZATION; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY BYPASS GRAFT; ECHOCARDIOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; SYNCOPE;

AORTIC VALVE; AORTIC VALVE STENOSIS; BIOPROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; THROMBOSIS;

EID: 79957681723     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2011.01.099     Document Type: Article

References (8)

1. Jamieson WR, Burr LH, Munro AI, Miyagishima RT. Carpentier- Edwards standard porcine bioprosthesis: a 21-year experience. Ann Thorac Surg 1998;66(Suppl):40-3.
2. Crum-Cianflone NF, Weekes J, Bavaro M. Thromboses among HIV-infected patients during the highly active antiretroviral therapy era. AIDS Patient Care STDS 2008;22: 771-8.
3. Pulik M LdHS, Coudere LJ. Unexplained venous thrombotic disease in HIV-infected patients. Paper presented at: Sixth International Conference on AIDS; June 20-23, 1990; San Francisco, CA. Abstract 2038.
4. Franchini M, Mannucci PM. Venous and arterial thrombosis: different sides of the same coin? Eur J Intern Med 2008;19: 476-81.
5. Feffer SE, Fox RL, Orsen MM, Harjai KJ, Glatt AE. Thrombotic tendencies and correlation with clinical status in patients infected with HIV. South Med J 1995;88:1126-30.
6. Fisher SD, Miller TL, Lipshultz SE. Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis. Atherosclerosis 2006;185:1-11. (Pubitemid 43117545)
7. de Larranaga GF, Petroni A, Deluchi G, Alonso BS, Benetucci JA. Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients. Blood Coagul Fibrinolysis 2003;14:15-8. (Pubitemid 36206717)
8. Wolf K, Tsakiris DA, Weber R, Erb P, Battegay M. Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1. J Infect Dis 2002;185:456-62. (Pubitemid 34142807)